A20 as a Potential New Tool in Predicting Recurrence and Patient's Survival in Oral Squamous Cell Carcinoma

A20, known as a potent inhibitor of NF-κB signaling, has been characterized in numerous clinical as well as preclinical studies. Recently, especially in various malignant diseases, the prognostic and therapeutic relevance of A20 was investigated. In oral squamous cell carcinoma (OSCC) however, the c...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2023-01, Vol.15 (3), p.675
Hauptverfasser:	Spoerl, Steffen, Erber, Ramona, Gerken, Michael, Taxis, Juergen, Ludwig, Nils, Nieberle, Felix, Biermann, Niklas, Geppert, Carol Immanuel, Ettl, Tobias, Hartmann, Arndt, Beckhove, Philipp, Reichert, Torsten E, Spanier, Gerrit, Spoerl, Silvia
Format:	Artikel
Sprache:	eng
Schlagworte:	A20 protein Blood diseases Cancer Care and treatment CD3 antigen Cell survival Cells Chemokines Cloning Cohort analysis Comorbidity Complications and side effects Cytokines Gene expression Inflammation Liver cancer Lymphatic system Lymphocytes Mouth cancer NF-κB protein Oral carcinoma Oral squamous cell carcinoma Patients Physiology Prognosis Radiation therapy Relapse Software Squamous cell carcinoma Statistical analysis Survival analysis Tumor cells Tumor necrosis factor-TNF Tumor-infiltrating lymphocytes Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!